• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Monday’s call for Repatha


<















































Easy Sanofi loser - you have minimal market share. We wiped you out


No, its not about the $$ and market share … No I just love the Fact that Sanofi and Regeneron just unveiled who Amgen really is….Trying to get blood out of a rock!

What a waste of time and money in lawyer fees… Only to Lose!! Bhahahaha.
 




No, its not about the $$ and market share … No I just love the Fact that Sanofi and Regeneron just unveiled who Amgen really is….Trying to get blood out of a rock!

What a waste of time and money in lawyer fees… Only to Lose!! Bhahahaha.

It appears it IS about the market share to you. It appears you ARE one of the losers that sold praluent. You actually spent time coming on our page. YOU have wasted your time.
 








Similar threads